bruceleeboy
$INVO Interesting thesis. I could see some news coming in the fall. Yaday Health presumably has a role to play; increasing its value. Soriot mentioned AZ not needing a major acquisition since they have such a robust internal pipeline. Still targeting $80B by 2030. Clearly he believes there’s serious untapped value under the hood.
2